Figures & data
Figure 2 Consort diagram for study sample.
![Figure 2 Consort diagram for study sample.](/cms/asset/ef5a7701-490d-4b11-bc22-c5b74e42bb36/dcop_a_12163903_f0002_b.jpg)
Table 1 Baseline Demographics and Clinical Characteristics of Study Cohort
Table 2 All-Cause and COPD-Related HCRU in the 12 and 24 Months Following MITT Initiation for Early (≤30 Days) versus Delayed (31–180 Days) MITT Initiators
Figure 3 All-cause and COPD-related direct healthcare costs following MITT initiation in early (≤30 days) versus delayed (31–180 days) MITT initiators, at (A) 12 months and (B) 24 months, following MITT initiation.
![Figure 3 All-cause and COPD-related direct healthcare costs following MITT initiation in early (≤30 days) versus delayed (31–180 days) MITT initiators, at (A) 12 months and (B) 24 months, following MITT initiation.](/cms/asset/a316503b-7969-4b48-8ef4-67e8fe570a17/dcop_a_12163903_f0003_c.jpg)
Table 3 Frequency of Exacerbations in the 12 and 24 Months Following MITT Initiation for Early (≤30 Days) versus Delayed (31–180 Days) MITT Initiators